Hyperthermic intraperitoneal chemotherapy (HIPEC): Should we look closer at the microenvironment? (Q98174930)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32732012 AND SRC:MED&resulttype=core&format=json

9 August 2020

title

Hyperthermic intraperitoneal chemotherapy (HIPEC): Should we look closer at the microenvironment? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32732012 AND SRC:MED&resulttype=core&format=json

9 August 2020

author name string

Adrien Crestani

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32732012 AND SRC:MED&resulttype=core&format=json

9 August 2020

Louise Benoit

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32732012 AND SRC:MED&resulttype=core&format=json

9 August 2020

Cyril Touboul

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32732012 AND SRC:MED&resulttype=core&format=json

9 August 2020

Jennifer Pasquier

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32732012 AND SRC:MED&resulttype=core&format=json

9 August 2020

publication date

27 July 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32732012 AND SRC:MED&resulttype=core&format=json

9 August 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32732012 AND SRC:MED&resulttype=core&format=json

Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer.

9 August 2020

cites work

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2020.07.017

It's time to warm up to hyperthermic intraperitoneal chemotherapy for patients with ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2020.07.017

Tumour-microenvironmental interactions: paths to progression and targets for treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2020.07.017

Targeting Tumor Microenvironment for Cancer Therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2020.07.017

Tumor associated mesenchymal stem cells protects ovarian cancer cells from hyperthermia through CXCL12.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2020.07.017

Sensitivity of hyperthermia trial outcomes to temperature and time: implications for thermal goals of treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2020.07.017

Incorporation of paclitaxel-based hyperthermic intraperitoneal chemotherapy in patients with advanced-stage ovarian cancer treated with neoadjuvant chemotherapy followed by interval debulking surgery: a protocol-based pilot study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2020.07.017

Hyperthermia in combined treatment of cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2020.07.017

Intraperitoneal cisplatin and paclitaxel in ovarian cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2020.07.017

Factors associated with improved toxicity and tolerability of intraperitoneal chemotherapy in advanced-stage epithelial ovarian cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2020.07.017

Feasibility of a modified outpatient regimen of intravenous/intraperitoneal chemotherapy in optimally debulked stage III ovarian cancer patients: a GEICO study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2020.07.017

Randomized Trial of Intravenous Versus Intraperitoneal Chemotherapy Plus Bevacizumab in Advanced Ovarian Carcinoma: An NRG Oncology/Gynecologic Oncology Group Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2020.07.017

Extent of parietal peritonectomy does not change intraperitoneal chemotherapy pharmacokinetics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2020.07.017

Potentiation of platinum analogue cytotoxicity by hyperthermia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2020.07.017

Intraperitoneal carboplatin infusion may be a pharmacologically more reasonable route than intravenous administration as a systemic chemotherapy. A comparative pharmacokinetic analysis of platinum using a new mathematical model after intraperitoneal

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2020.07.017

Pentetration of carboplatin and cisplatin into rat peritoneal tumor nodules after intraperitoneal chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2020.07.017

Current practice in cytoreductive surgery and HIPEC for metastatic peritoneal disease: Spanish multicentric survey

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2020.07.017

CCL2/CCL5 secreted by the stroma induce IL-6/PYK2 dependent chemoresistance in ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2020.07.017

Overview of extracellular matrix

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2020.07.017

Overview of the matrisome--an inventory of extracellular matrix constituents and functions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2020.07.017

Motility of select ovarian cancer cell lines: effect of extra-cellular matrix proteins and the involvement of PAK2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2020.07.017

Expression of the collagen-related heat shock protein HSP47 in fibroblasts treated with hyperthermia or photodynamic therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2020.07.017

Versican in epithelial ovarian cancer: Relation to hyaluronan, clinicopathologic factors and prognosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2020.07.017

Versican and vascular endothelial growth factor expression levels in peritoneal metastases from colorectal cancer are associated with survival after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2020.07.017

Mesenchymal stem cells: revisiting history, concepts, and assays.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2020.07.017

The elusive nature and function of mesenchymal stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2020.07.017

Lysophosphatidic acid in malignant ascites stimulates migration of human mesenchymal stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2020.07.017

Role of mesenchymal cells in the natural history of ovarian cancer: a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2020.07.017

Immunogenic potential of human bone marrow mesenchymal stromal cells is enhanced by hyperthermia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2020.07.017

Surgical peritoneal stress creates a pro-metastatic niche promoting resistance to apoptosis via IL-8

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2020.07.017

IL-8, GRO and MCP-1 produced by hepatocellular carcinoma microenvironment determine the migratory capacity of human bone marrow-derived mesenchymal stromal cells without affecting tumor aggressiveness.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2020.07.017

The prognostic value of tumor-infiltrating T lymphocytes in ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2020.07.017

Tumor infiltrating lymphocytes in ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2020.07.017

A tissue-specific endothelial cell molecule involved in lymphocyte homing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2020.07.017

The mucosal vascular addressin is a tissue-specific endothelial cell adhesion molecule for circulating lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2020.07.017

IL-6 trans-signaling licenses mouse and human tumor microvascular gateways for trafficking of cytotoxic T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2020.07.017

Heat shock enhances the expression of cytotoxic granule proteins and augments the activities of tumor-associated antigen-specific cytotoxic T lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2020.07.017

Fas ligand gene expression is directly regulated by stress-inducible heat shock transcription factor-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2020.07.017

Targeted inhibition of heat shock protein 90 suppresses tumor necrosis factor-α and ameliorates murine intestinal inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2020.07.017

CD91-dependent programming of T-helper cell responses following heat shock protein immunization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2020.07.017

Effector T Cells Abrogate Stroma-Mediated Chemoresistance in Ovarian Cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2020.07.017

B cell regulation in cancer and anti-tumor immunity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2020.07.017

Prognostic impact of tumour-associated B cells and plasma cells in epithelial ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2020.07.017

Activation signals regulate heat shock transcription factor 1 in human B lymphocytes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2020.07.017

HSP90alpha and HSP90beta isoforms selectively modulate MHC class II antigen presentation in B cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2020.07.017

Mammary-tumor-educated B cells acquire LAP/TGF-β and PD-L1 expression and suppress anti-tumor immune responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2020.07.017

Regulatory B cells contribute to the impaired antitumor immunity in ovarian cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2020.07.017

Macrophages: Obligate Partners for Tumor Cell Migration, Invasion, and Metastasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2020.07.017

Cisplatin-stimulated macrophages promote ovarian cancer migration via the CCL20-CCR6 axis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2020.07.017

HSF1 Is a Transcriptional Activator of IL-10 Gene Expression in RAW264.7 Macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2020.07.017

The influence of hyperthermia in vitro on the functions of peritoneal macrophages in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2020.07.017

Understanding dendritic cell immunotherapy in ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2020.07.017

Dendritic Cells Loaded with Heat Shock-Conditioned Ovarian Epithelial Carcinoma Cell Lysates Elicit T Cell-Dependent Antitumor Immune Responses In Vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2020.07.017

Exosomes from heat-stressed tumour cells inhibit tumour growth by converting regulatory T cells to Th17 cells via IL-6.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2020.07.017

TLR4 is essential for dendritic cell activation and anti-tumor T-cell response enhancement by DAMPs released from chemically stressed cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2020.07.017

Fever-like temperature induces maturation of dendritic cells through induction of hsp90.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2020.07.017

Increase of NKG2D ligands and sensitivity to NK cell-mediated cytotoxicity of tumor cells by heat shock and ionizing radiation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2020.07.017

Heat shock protein 70-reactivity is associated with increased cell surface density of CD94/CD56 on primary natural killer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2020.07.017

Hyperthermia suppresses the cytotoxicity of NK cells via down-regulation of perforin/granzyme B expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2020.07.017

Final Overall Survival of a Randomized Trial of Bevacizumab for Primary Treatment of Ovarian Cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2020.07.017

Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2020.07.017

The effect of mild temperature hyperthermia on tumour hypoxia and blood perfusion: relevance for radiotherapy, vascular targeting and imaging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2020.07.017

Instructive role of the vascular niche in promoting tumour growth and tissue repair by angiocrine factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2020.07.017

Akt-activated endothelium promotes ovarian cancer proliferation through notch activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2020.07.017

Endothelial cells provide a notch-dependent pro-tumoral niche for enhancing breast cancer survival, stemness and pro-metastatic properties

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2020.07.017

Angiocrine endothelium: from physiology to cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2020.07.017

Hsp90 isoforms: functions, expression and clinical importance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2020.07.017

89Zr-bevacizumab PET of early antiangiogenic tumor response to treatment with HSP90 inhibitor NVP-AUY922.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2020.07.017

The proangiogenic phenotype of human tumor-derived endothelial cells depends on thrombospondin-1 downregulation via phosphatidylinositol 3-kinase/Akt pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2020.07.017

Exosomal transfer of stroma-derived miR21 confers paclitaxel resistance in ovarian cancer cells through targeting APAF1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2020.07.017

Heat shock proteins: in vivo heat treatments reveal adipose tissue depot-specific effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2020.07.017

Fatty acid-binding protein FABP4 mechanistically links obesity with aggressive AML by enhancing aberrant DNA methylation in AML cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2020.07.017

Differential proteomics of omental and subcutaneous adipose tissue reflects their unalike biochemical and metabolic properties

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2020.07.017

Heat shock protein 70 is translocated to lipid droplets in rat adipocytes upon heat stimulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGYNO.2020.07.017

10.1016/J.YGYNO.2020.07.017

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32732012 AND SRC:MED&resulttype=core&format=json

9 August 2020

1 reference